| Risk of anaphylaxis after vaccination in children and adults MM McNeil, ES Weintraub, J Duffy, L Sukumaran, SJ Jacobsen, NP Klein, ... Journal of allergy and clinical immunology 137 (3), 868-878, 2016 | 455 | 2016 |
| Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings MG Thompson, E Stenehjem, S Grannis, SW Ball, AL Naleway, TC Ong, ... New England Journal of Medicine 385 (15), 1355-1371, 2021 | 454 | 2021 |
| Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during … JM Ferdinands MMWR. Morbidity and mortality weekly report 71, 2022 | 441 | 2022 |
| Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of … MG Thompson MMWR. Morbidity and mortality weekly report 71, 2022 | 439 | 2022 |
| Risk of intussusception after monovalent rotavirus vaccination ES Weintraub, J Baggs, J Duffy, C Vellozzi, EA Belongia, S Irving, ... New England Journal of Medicine 370 (6), 513-519, 2014 | 243 | 2014 |
| Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth—eight integrated health care organizations, United States, December 15, 2020 … HS Lipkind MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 196 | 2022 |
| Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections EA Belongia, SA Irving, SC Waring, LA Coleman, JK Meece, ... Jama 304 (10), 1091-1098, 2010 | 194 | 2010 |
| Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care encounters and hospitalizations among … NP Klein MMWR. Morbidity and mortality weekly report 71, 2022 | 185 | 2022 |
| Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort SA Irving, JG Donahue, DK Shay, TL Ellis-Coyle, EA Belongia Vaccine 27 (47), 6546-6549, 2009 | 185 | 2009 |
| COVID-19 vaccination coverage among pregnant women during pregnancy—eight integrated health care organizations, United States, December 14, 2020–May 8, 2021 H Razzaghi MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 182 | 2021 |
| Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 … MG Thompson, DK Li, P Shifflett, LZ Sokolow, JR Ferber, S Kurosky, ... Clinical infectious diseases 58 (4), 449-457, 2014 | 181 | 2014 |
| Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January–September 2021 PJ Embi MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 170 | 2021 |
| Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine EA Belongia, SA Irving, IM Shui, M Kulldorff, E Lewis, R Yin, TA Lieu, ... The Pediatric infectious disease journal 29 (1), 1-5, 2010 | 151 | 2010 |
| H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project GM Lee, SK Greene, ES Weintraub, J Baggs, M Kulldorff, BH Fireman, ... American journal of preventive medicine 41 (2), 121-128, 2011 | 137 | 2011 |
| Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008 SA Irving, DC Patel, BA Kieke, JG Donahue, MF Vandermause, DK Shay, ... Influenza and other respiratory viruses 6 (1), 37-43, 2012 | 130 | 2012 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 129 | 2022 |
| Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study JM Ferdinands, S Rao, BE Dixon, PK Mitchell, MB DeSilva, SA Irving, ... bmj 379, 2022 | 127 | 2022 |
| Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19–like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity—nine states, January … CH Bozio MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 127 | 2021 |
| Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12 JG Donahue, BA Kieke, JP King, F DeStefano, MA Mascola, SA Irving, ... Vaccine 35 (40), 5314-5322, 2017 | 118 | 2017 |
| Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA. 1 and BA. 2/BA. 2.12. 1 sublineages … R Link-Gelles MMWR. Morbidity and mortality weekly report 71, 2022 | 107 | 2022 |
